The Valley Desk

NCT02628535 · Interventional trial

Safety Study of MGD009 in B7-H3-expressing Tumors

Overall registry status Terminated

Phase 1

Conditions Bladder Cancer, Breast Cancer, Clear Cell Renal Cell Carcinoma, Colon Cancer, Melanoma, Mesothelioma, Non Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Soft Tissue Sarcoma, Squamous Cell Carcinoma of the Head and Neck, Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov